BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 590342)

  • 1. Effect of intracerebroventricular administration of morphine upon intestinal motility in rat and its antagonism with naloxone.
    Parolaro D; Sala M; Gori E
    Eur J Pharmacol; 1977 Dec; 46(4):329-38. PubMed ID: 590342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central and peripheral components of dermorphin's effect on rat intestinal propulsion in comparison to morphine.
    Parolaro D; Sala M; Crema G; Spazzi L; Cesana R; Gori E
    Peptides; 1983; 4(1):55-8. PubMed ID: 6866810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect on intestinal transit of neurotensin administered intracerebroventricularly to rats.
    Parolaro D; Sala M; Crema G; Spazzi L; Gori E
    Life Sci; 1983; 33 Suppl 1():485-8. PubMed ID: 6664230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Centrally mediated inhibition of small intestinal transit and motility by morphine in the rat.
    Galligan JJ; Burks TF
    J Pharmacol Exp Ther; 1983 Aug; 226(2):356-61. PubMed ID: 6875849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central and peripheral inhibitory effects of morphine on intestinal transit in mice.
    Wong CL
    Methods Find Exp Clin Pharmacol; 1986 Aug; 8(8):479-83. PubMed ID: 3747641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central and peripheral inhibition of gastrointestinal transit in rats: narcotics differ substantially by acting at either or both levels.
    Peracchia F; Bianchi G; Fiocchi R; Petrillo P; Tavani A; Manara L
    J Pharm Pharmacol; 1984 Oct; 36(10):699-701. PubMed ID: 6150093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Further investigations on neurotensin as central modulator of intestinal motility in rats.
    Parolaro D; Sala M; Patrini G; Biffi E; Pecora N; Gori E
    Regul Pept; 1987 Feb; 17(2):111-7. PubMed ID: 3107088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antipropulsive effects of central and peripheral morphine in the rat gastrointestinal tract.
    Stewart JJ; Curd CD
    J Pharm Pharmacol; 1984 Jul; 36(7):476-7. PubMed ID: 6146697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal of the effects of centrally-administered morphine on colonic motility in dogs by the benzodiazepine receptor antagonist RO 15-1788.
    Fioramonti J; Fargeas MJ; Buéno L
    Life Sci; 1987 Sep; 41(12):1449-55. PubMed ID: 3041141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Independent central and peripheral mediation of morphine-induced inhibition of gastrointestinal transit in rats.
    Gmerek DE; Cowan A; Woods JH
    J Pharmacol Exp Ther; 1986 Jan; 236(1):8-13. PubMed ID: 3941402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pertussis toxin modifies the effect of central morphine on rat intestinal motility.
    Parolaro D; Patrini G; Massi P; Parenti M; Rubino T; Giagnoni G; Gori E
    Eur J Pharmacol; 1990 Feb; 177(1-2):75-80. PubMed ID: 2160368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of gastrointestinal transit by morphine in rats results primarily from direct drug action on gut opioid sites.
    Manara L; Bianchi G; Ferretti P; Tavani A
    J Pharmacol Exp Ther; 1986 Jun; 237(3):945-9. PubMed ID: 3012075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different targets for i.v. vs. i.c.v. administered morphine for its effect on colonic motility in dogs.
    Fioramonti J; Fargeas MJ; Bueno L
    Eur J Pharmacol; 1985 Oct; 117(1):115-20. PubMed ID: 4085540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histamine as a central modulator of rat intestinal transit.
    Parolaro D; Patrini G; Massi P; Mainardi P; Giagnoni G; Sala M; Gori E
    J Pharmacol Exp Ther; 1989 Apr; 249(1):324-8. PubMed ID: 2565394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for serotonergic system involvement in the effect of morphine on gastrointestinal motility in the rat.
    Pourgholami MH; Goshadrou F
    Gen Pharmacol; 1995 Jul; 26(4):779-83. PubMed ID: 7635252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The peripheral narcotic antagonist N-allyl levallorphan-bromide (CM 32191) selectively prevents morphine antipropulsive action and buprenorphine in-vivo binding in the rat intestine.
    Bianchi G; Fiocchi R; Peracchia F; Petrillo P; Tavani A; Manara L
    J Pharm Pharmacol; 1984 May; 36(5):326-30. PubMed ID: 6145770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A study on the antagonism of the intestinal inhibitory effects of morphine and clonidine by yohimbine in mice.
    Wong CL
    Methods Find Exp Clin Pharmacol; 1986 Dec; 8(12):715-9. PubMed ID: 3027469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time course of antagonism of morphine antinociception by intracerebroventricularly administered naloxone in the rat.
    Porreca F; Cowan A; Tallarida RJ
    Eur J Pharmacol; 1981 Nov; 76(1):55-9. PubMed ID: 7318922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative effects of prolyl-leucyl-glycinamide and naloxone on morphine-induced inhibition of gastrointestinal transit.
    Pillai NP; Bhargava HN
    Pharmacol Biochem Behav; 1984 Sep; 21(3):365-8. PubMed ID: 6149566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Further investigations on the antipropulsive effect of centrally administered histamine and its relation with morphine.
    Patrini G; Massi P; Rubino T; Donin L; Gori E; Parolaro D
    Eur J Pharmacol; 1992 Jan; 210(3):259-64. PubMed ID: 1612102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.